NanoViricides, Inc. (NYSE Amer.: NNVC ) (the “Company”), a clinical stage global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R. Diwan, Ph.D., the Company’s President ...

Research provides evidence that a drug used to slow the progression of the disease ALS shows promise in suppressing the self-renewing cancerous stem cells that challenge the present standards of care ...

In a pioneering study, study, researchers have demonstrated that metformin, a common diabetes drug, can slow the growth of ...

One of two new studies found most patients doing well six years after treatment. Another study found blood cancers in 17% of ...

Neuroinflammation drives the progression of neurodegenerative disorders like Alzheimer's, Parkinson's, and multiple sclerosis. Targeting neuroinflammation with small molecules is promising, but ...

A Montgomery County mother found 42 drug treatment programs for her son. Here’s what families can face as they seek care.

The U.S. Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), has taken ...

Emory wins $8.3 million grant from the National Institutes for Health that will support a project that aims to develop novel ...

Researchers have found that combining tolerogenic dendritic cells with Dimethyl Fumarate improves treatment efficacy for ...

Researchers who evaluated the Madison Area Recovery Initiative (MARI) found that non-violent offenders who were given a ...

“The doctor can use these models to decide what type of treatment to give to the patient. They also know the probable outcome and the follow-up required, how long the patient must remain in hospital, ...

Common measures of this model include the provision of free and ... even though studies show that SCS do not cause more drug-related crime. Nonetheless, soon after the report came out, the Alberta ...